Yu‐Ching Lee

999 total citations
43 papers, 805 citations indexed

About

Yu‐Ching Lee is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Yu‐Ching Lee has authored 43 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Oncology. Recurrent topics in Yu‐Ching Lee's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (7 papers) and Venomous Animal Envenomation and Studies (4 papers). Yu‐Ching Lee is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (7 papers) and Venomous Animal Envenomation and Studies (4 papers). Yu‐Ching Lee collaborates with scholars based in Taiwan, United States and China. Yu‐Ching Lee's co-authors include Keng‐Chang Tsai, Wang-Chuan Chen, Tien‐Sheng Tseng, Nai‐Wan Hsiao, Yun-Lian Lin, Chin-Chuan Tsai, Zhi‐Hong Wen, Sy‐Jye Leu, Nai-Wan Hsiao and An‐Suei Yang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yu‐Ching Lee

43 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ching Lee Taiwan 18 387 172 146 98 97 43 805
Shijun Li China 21 887 2.3× 49 0.3× 89 0.6× 97 1.0× 96 1.0× 75 1.5k
Ding Li China 19 824 2.1× 59 0.3× 103 0.7× 55 0.6× 103 1.1× 37 1.0k
Shan Feng China 17 494 1.3× 91 0.5× 85 0.6× 160 1.6× 17 0.2× 54 1.0k
Rangaiah Shashidharamurthy United States 23 615 1.6× 92 0.5× 86 0.6× 383 3.9× 54 0.6× 54 1.5k
Gladys C. Completo United States 13 700 1.8× 107 0.6× 33 0.2× 245 2.5× 43 0.4× 35 1.0k
Ju Bao United States 14 516 1.3× 29 0.2× 76 0.5× 60 0.6× 23 0.2× 32 839
Abhay H. Pande India 18 548 1.4× 44 0.3× 140 1.0× 216 2.2× 43 0.4× 81 1.1k
Flora Cozzolino Italy 20 675 1.7× 22 0.1× 130 0.9× 106 1.1× 107 1.1× 48 1.1k
Saikat Chakrabarti India 19 609 1.6× 47 0.3× 60 0.4× 99 1.0× 16 0.2× 57 1.1k
Chhabinath Mandal India 21 705 1.8× 94 0.5× 66 0.5× 308 3.1× 24 0.2× 56 1.1k

Countries citing papers authored by Yu‐Ching Lee

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ching Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ching Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ching Lee more than expected).

Fields of papers citing papers by Yu‐Ching Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ching Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ching Lee. The network helps show where Yu‐Ching Lee may publish in the future.

Co-authorship network of co-authors of Yu‐Ching Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ching Lee. A scholar is included among the top collaborators of Yu‐Ching Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ching Lee. Yu‐Ching Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Tsai‐Yu, Yi-Hui Lin, Jou‐Ho Shih, et al.. (2024). Paclitaxel-resistance facilitates glycolytic metabolism via Hexokinase-2-regulated ABC and SLC transporter genes in ovarian clear cell carcinoma. Biomedicine & Pharmacotherapy. 180. 117452–117452. 3 indexed citations
2.
Lin, Jiun-Han, et al.. (2024). Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient. Biochemical and Biophysical Research Communications. 735. 150839–150839. 1 indexed citations
3.
Tsai, Keng‐Chang, et al.. (2023). Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment. Heliyon. 9(11). e21774–e21774. 2 indexed citations
4.
Lin, Tsai‐Yu, et al.. (2023). Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer. Biochemical and Biophysical Research Communications. 680. 161–170. 1 indexed citations
5.
Sung, Ting-Yi, Han-Li Huang, Po‐Li Wei, et al.. (2021). EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody. Cell & Bioscience. 11(1). 53–53. 11 indexed citations
6.
Tsai, Keng‐Chang, Tsai‐Yu Lin, Wang-Chuan Chen, et al.. (2020). Astragalus membranaceus–Derived Anti‐Programmed Death‐1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors. BioMed Research International. 2020(1). 3415471–3415471. 18 indexed citations
7.
Lee, Yu‐Ching, Tsai‐Yu Lin, Mei‐Kuang Lu, et al.. (2020). Isolation of anti-VEGF monoclonal antibodies with neutralizing effects from an Astragalus-induced immune antibody library. International Immunopharmacology. 88. 107007–107007. 11 indexed citations
8.
9.
Lee, Yu‐Ching, et al.. (2019). Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway. Journal of Biomedical Science. 26(1). 96–96. 32 indexed citations
10.
Lang, Yaw‐Dong, Hsin‐Yi Chen, Jou‐Ho Shih, et al.. (2019). PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression. Nature Communications. 10(1). 5716–5716. 31 indexed citations
11.
Lin, Tsai‐Yu, et al.. (2018). Interaction of S17 Antibody with the Functional Binding Region of the Hepatitis B Virus Pre-S2 Epitope. Viral Immunology. 31(7). 492–499. 7 indexed citations
12.
Chen, Chun‐Han, Chun A. Changou, Tsung‐Han Hsieh, et al.. (2017). Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer. Clinical Cancer Research. 24(5). 1176–1189. 43 indexed citations
13.
Chao, Min‐Wu, Han-Li Huang, Yu-Wei Chang, et al.. (2017). Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells. Scientific Reports. 7(1). 46134–46134. 35 indexed citations
14.
Tseng, Tien‐Sheng, Show‐Mei Chuang, Nai-Wan Hsiao, et al.. (2016). Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations. Molecular BioSystems. 12(8). 2541–2551. 7 indexed citations
15.
Lee, Yu‐Ching, Nai‐Wan Hsiao, Tien‐Sheng Tseng, et al.. (2014). Phage Display–Mediated Discovery of Novel Tyrosinase-Targeting Tetrapeptide Inhibitors Reveals the Significance of N-Terminal Preference of Cysteine Residues and Their Functional Sulfur Atom. Molecular Pharmacology. 87(2). 218–230. 26 indexed citations
16.
Jian, Jhih-Wei, Hung‐Ju Chang, Yu‐Ching Lee, et al.. (2013). Antibody Variable Domain Interface and Framework Sequence Requirements for Stability and Function by High-Throughput Experiments. Structure. 22(1). 22–34. 22 indexed citations
17.
Chang, Hung‐Ju, Jhih-Wei Jian, Yu‐Ching Lee, et al.. (2013). Loop-Sequence Features and Stability Determinants in Antibody Variable Domains by High-Throughput Experiments. Structure. 22(1). 9–21. 29 indexed citations
18.
Peng, Hung‐Pin, Yu‐Ching Lee, Keng‐Chang Tsai, et al.. (2012). Rationalization and Design of the Complementarity Determining Region Sequences in an Antibody-Antigen Recognition Interface. PLoS ONE. 7(3). e33340–e33340. 43 indexed citations
19.
Lee, Yu‐Ching, et al.. (2010). Signal sequence as a determinant in expressing disulfide-stabilized single chain antibody variable fragments (sc-dsFv) against human VEGF. Molecular BioSystems. 6(7). 1307–1315. 1 indexed citations
20.
Lee, Yu‐Ching, et al.. (2007). A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage. Veterinary Immunology and Immunopathology. 117(1-2). 75–85. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shijun Li Breakdown of academic impact, for papers by Ding Li Breakdown of academic impact, for papers by Shan Feng Breakdown of academic impact, for papers by Rangaiah Shashidharamurthy Breakdown of academic impact, for papers by Gladys C. Completo Breakdown of academic impact, for papers by Ju Bao Breakdown of academic impact, for papers by Abhay H. Pande Breakdown of academic impact, for papers by Flora Cozzolino Breakdown of academic impact, for papers by Saikat Chakrabarti Breakdown of academic impact, for papers by Chhabinath Mandal
Rankless by CCL
2026